相关实验视频

Updated: Jun 30, 2025

Visualization of Amyloid β Deposits in the Human Brain with Matrix-assisted Laser Desorption/Ionization Imaging Mass Spectrometry

Visualization of Amyloid β Deposits in the Human Brain with Matrix-assisted Laser Desorption/Ionization Imaging Mass Spectrometry

Published on: March 7, 2019

阿尔德海德脱酶2 rs671变体增强了粉样β病理

Xia Wang¹, Jiayu Wang¹, Yashuang Chen¹

¹Department of Immunology, Institute of Basic Medical Sciences Chinese Academy of Medical Sciences, School of Basic Medicine Peking Union Medical College, Beijing, China.

Nature communications

|March 23, 2024

概括

ALDH2 rs671 变种降低了酶活性,影响了阿尔茨海默病. 虽然与粉样蛋白斑有关,但它不是一个独立的风险因素,而是粉样蛋白β生成的关键调节者.

科学领域:

神经科学是一个神经科学.
遗传学是一个遗传学.
生物化学生物化学

背景情况:

这种ALDH2 rs671变体显著降低了酶活性.
关于该变种与阿尔茨海默氏病 (AD) 风险的联系的人口数据是相互矛盾的.
东亚人群中,ALDH2 rs671变种的流行率很高 (30-50%).

研究的目的:

为了研究ALDH2rs671多态和阿尔茨海默病病理学之间的关联.
阐明ALDH2活性与粉样β (Aβ) 生成之间的机制联系.

主要方法:

来自国家人类大脑开发和功能银行 (National Human Brain Bank for Development and Function) 的469个死后大脑的分析.
生物化学测试以评估ALDH2活性,4-HNE积累和Aβ40/42比率.
研究与Aβ相关的炎症标志物和细胞活性.

主要成果:

ALDH2 rs671变异与粉样蛋白斑块沉积增加和Aβ40/42比率升高相关.
较低的ALDH2活性导致4-氨酸 (4-HNE) 积累,促进Aβ40生成.
降低ALDH2活性与减少炎症因子分泌和受损的Aβ细胞化有关.

结论:

ALDH2 rs671变种不是阿尔茨海默病的独立风险因素.
ALDH2 rs671被确定为Aβ40和Aβ42生成的关键调节者.
这项研究阐明了ALDH2多态性和大脑中的粉样β病理之间的关系.

更多相关视频

Full- versus Sub-Regional Quantification of Amyloid-Beta Load on Mouse Brain Sections

Full- versus Sub-Regional Quantification of Amyloid-Beta Load on Mouse Brain Sections

Published on: May 19, 2022

Detecting Amyloid-β Accumulation via Immunofluorescent Staining in a Mouse Model of Alzheimer's Disease

Detecting Amyloid-β Accumulation via Immunofluorescent Staining in a Mouse Model of Alzheimer's Disease

Published on: April 19, 2021

相关概念视频

Amyloid Fibrils

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...

Alzheimer's Disease: Overview

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...